Abstract
To evaluate the efficacy and toxicity of 5-fluorouracil (5-FU) after pars plana vitrectomy, 51 eyes were followed in a prospective and randomized clinical trial in which, upon completion of surgery, 26 eyes received 10 mg intravitreal 5-FU and 25 control eyes did not receive 5-FU. The only possible sign of 5-FU toxicity was prolonged corneal epithelial edema. Visual acuities of 20/200 or better were obtained in 67% of the 5-FU group and 56% of the control group. Successful macular reattachment was obtained in 60% of the 5-FU group and 77% of the control group. None of the eyes in either group developed substantial intraocular proliferation or membranes. The findings indicate that a single 10-mg intravitreal injection of 5-FU is well tolerated without permanent toxic damage.
Similar content being viewed by others
References
Blankenship GW, Friedland BR, Blumenkranz M (1986) Ocular effects and clearance of intravitreal 5-fluorouracil. In: Blankenship GW, Binder S, Gonvers M, Stirpe M (eds) Basic and advanced vitreous surgery. Springer, Berlin Heidelberg New York, pp 415–419
Blumenkranz MS, Ophir A, Claflin AJ, Hajek A (1982) Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol 94:458–467
Blumenkranz MS, Hernandez E, Ophir A, Norton EWD (1984) 5-Fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 91:122–130
Blumenkranz MS, Hartzer MK, Hajek AS (1987) Selection of therapeutic agents for intraocular proliferative disease: II. Differing antiproliferative activity of the fluoropyrimidines. Arch Ophthalmol 105:396–399
Calabresi P, Parks RE (1980) Chemotherapy of neoplastic diseases. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacologic basis of therapeutics, 6th edn. MacMillan, New York, pp 1249–1255
Faulborn J, Conway BP, Machemer R (1978) Surgical complications of pars plana vitreous surgery. Ophthalmology 85:116–125
Gressel MG, Parrish RK, Folberg R (1984) 5-Fluorouracil and glaucoma filtering surgery: I. An animal model. Ophthalmology 91:378–383
Hatchell DL, McAdoo T, Sheta S, King RT, Bartolome JV (1988) Quantification of cellular proliferation in experimental proliferative vitreoretinopathy. Arch Ophthalmol 106:669–672
Heuer DK, Parrish RK, Gressel MG, Hodapp E, Palmberg PF, Anderson DR (1984) 5-Fluorouracil and glaucoma filtering surgery: II. A pilot study. Ophthalmology 91:384–394
Jarus G, Blumenkranz M, Hernandez E, Sossi N (1985) Clearance of intravitreal fluorouracil. Normal and aphakic vitrectomized eyes. Ophthalmology 92:91–96
Joondeph BC, Peyman GA, Khoobehi B, Yue BY (1988) Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy. Ophthalmic Surg 19:252–256
Lewis H, Abrams GW, Williams GA (1987) Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol 104:607–613
Machemer R (1987) Massive periretinal proliferation: a logical approach to therapy. Trans Am Ophthalmol Soc 75:556–586
Mallick KS, Hajek AS, Parrish RK (1985) Fluorouracil (5-FU) and cytarabine (Ara-C) inhibition of corneal epithelial cells and conjunctival fibrovascular proliferation. Arch Ophthalmol 103:1398–1402
Mannis MJ, Sweet EH, Lewis RA (1988) The effect of fluorouracil on the corneal endothelium. Arch Ophthalmol 106:616–617
Orr G, Tervaert DC, Lean JS (1986) Aqueous concentrations of fluorouracil after intravitreal injection. Normal, vitrectomized, and silicone-filled eyes. Arch Ophthalmol 104:431–434
Retina Society Terminology Committee (1983) The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90:121–125
Ruderman JM, Welch DB, Smith MF, Shoch DE (1987) A randomized study of 5-fluorouracil and filtration surgery. Am J Ophthalmol 104:218–224
Sebestyen JG (1982) Fibrinoid syndrome. A severe complication of vitrectomy surgery in diabetics. Ann Ophthalmol 14:853–856
Stern WH, Guerin CJ (1983) Ocular toxicity of fluorouracil after vitrectomy. Am J Ophthalmol 96:43–51
Vidaum-Leal JS, Glaser BM (1984) Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol 102:1376–1379
Author information
Authors and Affiliations
Additional information
This project was supported in part by patients and contributors of the Bascom Palmer Eye Institute, Research to Prevent Blindness, Inc., New York City; Florida Lions Eye Bank Laboratory; and the Brenn Green Diabetic Retinopathy Fund, Miami, Florida
Rights and permissions
About this article
Cite this article
Blankenship, G.W. Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases. Graefe's Arch Clin Exp Ophthalmol 227, 565–568 (1989). https://doi.org/10.1007/BF02169453
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02169453